Skip to content

The Proposed Study Aims to Investigate the Impact of Adjunctive Vitamin D Gel Application on Gingival Crevicular Fluid Levels of Alkaline Phosphatase and Interleukin-8 in Periodontitis Patients Undergoing Phase 1 Periodontal Therapy. By Elucidating the Molecular Mechanisms Underlying the Therapeutic

Therapeutic Efficacy of Local Vitamin D Drug as an Adjunct to Mechanical Debridement in the Treatment of Periodontitis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06669026
Enrollment
50
Registered
2024-11-01
Start date
2023-09-01
Completion date
2024-09-20
Last updated
2024-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Pocket

Brief summary

The proposed study aims to investigate the impact of adjunctive vitamin D gel application on gingival crevicular fluid levels of alkaline phosphatase and interleukin-8 in periodontitis patients undergoing phase 1 periodontal therapy. By elucidating the molecular mechanisms underlying the therapeutic effects of vitamin D, this research seeks to contribute to the development of more effective treatment strategies for periodontitis.

Interventions

DIETARY_SUPPLEMENTvitamin D loaded Poly lactic-co-glycolic acid nanoparticles gel

Scaling and root debridement then inject gel in the pocket

DIETARY_SUPPLEMENTvitamin D3 gel (regular non-nanoparticle form)

Scaling and root debridement then inject gel in the pocket

OTHERPoly lactic-co-glycolic acid nanoparticles placebo gel

Scaling and root debridement then inject gel in the pocket

PROCEDUREonly mechanical debridement

Scaling and root debridement

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Group 1: vitamin D3-loaded Poly lactic-co-glycolic acid (PLGA) nanoparticles gel as an adjunct to mechanical debridement. * Group 2: vitamin D3 gel (regular non-nanoparticle form) as an adjunct to mechanical debridement. * Group 3: placebo gel as an adjunct to mechanical debridement. * Group 4: only mechanical debridement.

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with attachment loss 3-4 mm * periodontal pocket ≤ 5 mm

Exclusion criteria

* \- Patients with sensitivity to the medication used in the study. * Patients with a history of antibiotic use or anti-inflammatory drugs during the previous 3 months prior to the study. * Patients with systemic diseases. * Pregnant and lactating females. * Smokers and tobacco chewers. * Patients not compliant with oral hygiene procedures.

Design outcomes

Primary

MeasureTime frameDescription
Periodontal Assessment12 weeksPeriodontal Index

Secondary

MeasureTime frameDescription
Interleukin 88 weekslevel of interleukin 8 in gingival crevicular fluid will be tested via elisa
alkaline phosphatase8 weekslevel of alkaline phosphatase in gingival crevicular fluid will be tested via elisa

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026